{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:07:35Z","timestamp":1789884455126,"version":"4.0.1"},"reference-count":226,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cervical cancer ranks as the fourth most prevalent cancer among women globally, with approximately 600,000 new cases being diagnosed each year. The principal driver of cervical cancer is the human papillomavirus (HPV), where viral oncoproteins E6 and E7 undertake the role of driving its carcinogenic potential. Despite extensive investigative efforts, numerous facets concerning HPV infection, replication, and pathogenesis remain shrouded in uncertainty. The virus operates through a variety of epigenetic mechanisms, and the epigenetic signature of HPV-related tumors is a major bottleneck in our understanding of the disease. Recent investigations have unveiled the capacity of viral oncoproteins to influence epigenetic changes within HPV-related tumors, and conversely, these tumors exert an influence on the surrounding epigenetic landscape. Given the escalating occurrence of HPV-triggered tumors and the deficiency of efficacious treatments, substantial challenges emerge. A promising avenue to address this challenge lies in epigenetic modulators. This review aggregates and dissects potential epigenetic modulators capable of combatting HPV-associated infections and diseases. By delving into these modulators, novel avenues for therapeutic interventions against HPV-linked cancers have come to the fore.<\/jats:p>","DOI":"10.3390\/cancers15235583","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T03:35:06Z","timestamp":1701056106000},"page":"5583","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Epigenetic and Genetic Keys to Fight HPV-Related Cancers"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-9882","authenticated-orcid":false,"given":"Veronica","family":"Folliero","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1654-8500","authenticated-orcid":false,"given":"Federica","family":"Dell\u2019Annunziata","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"},{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-4519","authenticated-orcid":false,"given":"Annalisa","family":"Chianese","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morone","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mensitieri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-6559","authenticated-orcid":false,"given":"Federica","family":"Di Spirito","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mollo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-6290","authenticated-orcid":false,"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-5018","authenticated-orcid":false,"given":"Fabrizio","family":"Dal Piaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-0655","authenticated-orcid":false,"given":"Pasquale","family":"Pagliano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cVincenzo Tiberio\u201d, Universit\u00e0 degli Studi del Molise, 86100 Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3321-4331","authenticated-orcid":false,"given":"Gianluigi","family":"Franci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses Associated with Human Cancer","volume":"1782","author":"Munger","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_3","first-page":"65","article-title":"Human Papilloma Virus: A Review Study of Epidemiology, Carcinogenesis, Diagnostic Methods, and Treatment of All HPV-Related Cancers","volume":"35","author":"Soheili","year":"2021","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, Y., and Zhou, X. (2022). N6-Methyladenosine and Its Implications in Viruses. Genom. Proteom. Bioinform.","DOI":"10.1016\/j.gpb.2022.04.009"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12985-023-02106-y","article-title":"Human Papillomavirus Spectrum of HPV-Infected Women in Nigeria: An Analysis by next-Generation Sequencing and Type-Specific PCR","volume":"20","author":"Ajang","year":"2023","journal-title":"Virol. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gusho, E., and Laimins, L. (2021). Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection. Viruses, 13.","DOI":"10.3390\/v13071390"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1586\/14760584.2014.933076","article-title":"Factors Impacting HPV Vaccination: Lessons for Health Care Professionals","volume":"13","author":"Hofstetter","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","article-title":"The Human Papillomavirus Replication Cycle, and Its Links to Cancer Progression: A Comprehensive Review","volume":"131","author":"Graham","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mac, M., and Moody, C.A. (2020). Epigenetic Regulation of the Human Papillomavirus Life Cycle. Pathogens, 9.","DOI":"10.3390\/pathogens9060483"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Soto, D., Song, C., and McLaughlin-Drubin, M.E. (2017). Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses, 9.","DOI":"10.3390\/v9090248"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrrev.2016.09.006","article-title":"Human Papillomaviruses in Epigenetic Regulations","volume":"772","author":"Durzynska","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pvr.2018.04.002","article-title":"HPV DNA Methylation at the Early Promoter and E1\/E2 Integrity: A Comparison between HPV16, HPV18 and HPV45 in Cervical Cancer","volume":"5","author":"Felix","year":"2018","journal-title":"Papillomavirus Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1112513","DOI":"10.3389\/fimmu.2023.1112513","article-title":"Human Papillomavirus in the Setting of Immunodeficiency: Pathogenesis and the Emergence of next-Generation Therapies to Reduce the High Associated Cancer Risk","volume":"14","author":"Hewavisenti","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103778","DOI":"10.1016\/j.critrevonc.2022.103778","article-title":"Unraveling Molecular Mechanisms of Head and Neck Cancer","volume":"178","author":"Antra","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fonc.2019.00355","article-title":"Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology","volume":"9","author":"Gheit","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Keiffer, T.R., Soorya, S., and Sapp, M.J. (2021). Recent Advances in Our Understanding of the Infectious Entry Pathway of Human Papillomavirus Type 16. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102076"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2016.11.010","article-title":"Papillomavirus Assembly: An Overview and Perspectives","volume":"231","author":"Cerqueira","year":"2017","journal-title":"Virus Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1073\/pnas.1600638113","article-title":"Incoming Human Papillomavirus Type 16 Genome Resides in a Vesicular Compartment throughout Mitosis","volume":"113","author":"DiGiuseppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Pe\u0161ut, E., \u0110uki\u0107, A., Luli\u0107, L., Skelin, J., \u0160imi\u0107, I., Milutin Ga\u0161perov, N., Tomai\u0107, V., Sabol, I., and Grce, M. (2021). Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge. Viruses, 13.","DOI":"10.3390\/v13112234"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Har\u0119\u017ca, D.A., Wilczy\u0144ski, J.R., and Paradowska, E. (2022). Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031818"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yu, L., Majerciak, V., and Zheng, Z.-M. (2022). HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094943"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1068449","DOI":"10.3389\/fimmu.2022.1068449","article-title":"Protein Post-Translational Modification in SARS-CoV-2 and Host Interaction","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/gbe\/evz095","article-title":"Genome Plasticity in Papillomaviruses and De Novo Emergence of E5 Oncogenes","volume":"11","author":"Willemsen","year":"2019","journal-title":"Genome Biol. Evol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Olmedo-Nieva, L., Mu\u00f1oz-Bello, J.O., Contreras-Paredes, A., and Lizano, M. (2018). The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis. Viruses, 10.","DOI":"10.3390\/v10010045"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e0068621","DOI":"10.1128\/JVI.00686-21","article-title":"Regulation of Human Papillomavirus 18 Genome Replication, Establishment, and Persistence by Sequences in the Viral Upstream Regulatory Region","volume":"95","author":"Coursey","year":"2021","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1128\/JVI.00965-16","article-title":"Serine\/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable Cis Elements","volume":"90","author":"Ajiro","year":"2016","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yilmaz, G., Biswas-Fiss, E.E., and Biswas, S.B. (2023). Sequence-Dependent Interaction of the Human Papillomavirus E2 Protein with the DNA Elements on Its DNA Replication Origin. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076555"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1038\/s41598-019-49886-4","article-title":"The Human Papillomavirus (HPV) E1 Protein Regulates the Expression of Cellular Genes Involved in Immune Response","volume":"9","author":"Lizano","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chojnacki, M., and Melendy, T. (2018). The HPV E2 Transcriptional Transactivation Protein Stimulates Cellular DNA Polymerase Epsilon. Viruses, 10.","DOI":"10.3390\/v10060321"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mu, Y., Tews, B.A., Luttermann, C., and Meyers, G. (2021). Interaction of Pestiviral E1 and E2 Sequences in Dimer Formation and Intracellular Retention. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147285"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/JVI.80.4.1787-1797.2006","article-title":"Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator","volume":"80","author":"Gammoh","year":"2006","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.4161\/cc.4.11.2123","article-title":"High-Risk but Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability","volume":"4","author":"Bellanger","year":"2005","journal-title":"Cell Cycle"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tim.2004.10.002","article-title":"Brd4: Tethering, Segregation and Beyond","volume":"12","author":"McBride","year":"2004","journal-title":"Trends Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.80.9.4580-4590.2006","article-title":"E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability to Bind P53 and Induce Apoptotic Cell Death","volume":"80","author":"Parish","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.2741\/1971","article-title":"Papillomavirus Genome Structure, Expression, and Post-Transcriptional Regulation","volume":"11","author":"Zheng","year":"2006","journal-title":"Front. Biosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e539s","DOI":"10.6061\/clinics\/2018\/e539s","article-title":"Human Papillomavirus and Genome Instability: From Productive Infection to Cancer","volume":"73","author":"Prati","year":"2018","journal-title":"Clinics"},{"key":"ref_37","first-page":"315","article-title":"Potential Role of E4 Protein in Human Papillomavirus Screening: A Review","volume":"18","author":"Yajid","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.virol.2007.05.043","article-title":"G2\/M Cell Cycle Arrest in the Life Cycle of Viruses","volume":"368","author":"Davy","year":"2007","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41388-020-01431-8","article-title":"HPV E2, E4, E5 Drive Alternative Carcinogenic Pathways in HPV Positive Cancers","volume":"39","author":"Ren","year":"2020","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Przybylski, M., Pruski, D., Millert-Kali\u0144ska, S., Krzy\u017caniak, M., de Mezer, M., Frydrychowicz, M., Jach, R., and \u017burawski, J. (2023). Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010225"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1476-4598-10-140","article-title":"Papillomavirus E5: The Smallest Oncoprotein with Many Functions","volume":"10","author":"Venuti","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"103923","DOI":"10.1016\/j.micpath.2019.103923","article-title":"Impact of HPV E5 on Viral Life Cycle via EGFR Signaling","volume":"139","author":"Ilahi","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13046-017-0541-1","article-title":"HrHPV E5 Oncoprotein: Immune Evasion and Related Immunotherapies","volume":"36","author":"Barros","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tomai\u0107, V. (2016). Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites. Cancers, 8.","DOI":"10.3390\/cancers8100095"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14195","DOI":"10.1038\/s41598-020-71134-3","article-title":"The Human Papillomavirus E6 Protein Targets Apoptosis-Inducing Factor (AIF) for Degradation","volume":"10","author":"Shimada","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, S., Hong, X., Wei, Z., Xie, M., Li, W., Liu, G., Guo, H., Yang, J., Wei, W., and Zhang, S. (2019). Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6\/E6AP-Mediated P53 Degradation. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02483"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"001540","DOI":"10.1099\/jgv.0.001540","article-title":"The Human Papillomavirus Oncoproteins: A Review of the Host Pathways Targeted on the Road to Transformation","volume":"102","author":"Scarth","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","article-title":"The Papillomavirus E7 Proteins","volume":"445","author":"Roman","year":"2013","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3567","article-title":"Molecular Mechanisms Underlying RB Protein Function","volume":"14","author":"Dick","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1099\/vir.0.035352-0","article-title":"Disruption of Repressive P130-DREAM Complexes by Human Papillomavirus 16 E6\/E7 Oncoproteins Is Required for Cell-Cycle Progression in Cervical Cancer Cells","volume":"92","author":"Yusof","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12985-015-0460-8","article-title":"HPV 16E7 and 48E7 Proteins Use Different Mechanisms to Target P130 to Overcome Cell Cycle Block","volume":"13","author":"Yong","year":"2016","journal-title":"Virol. J."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"James, C.D., Saini, S., Sesay, F., Ko, K., Felthousen-Rusbasan, J., Iness, A.N., Nulton, T., Windle, B., Dozmorov, M.G., and Morgan, I.M. (2021). Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells. Cancers, 13.","DOI":"10.3390\/cancers13030489"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tcb.2020.05.002","article-title":"Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin","volume":"30","author":"Emanuele","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1101\/gad.257568.114","article-title":"Structural Mechanisms of DREAM Complex Assembly and Regulation","volume":"29","author":"Guiley","year":"2015","journal-title":"Genes Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell Cycle Regulation: P53-P21-RB Signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.jmb.2014.10.021","article-title":"The High-Risk HPV16 E7 Oncoprotein Mediates Interaction between the Transcriptional Coactivator CBP and the Retinoblastoma Protein PRb","volume":"426","author":"Jansma","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Basukala, O., and Banks, L. (2021). The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis. Viruses, 13.","DOI":"10.3390\/v13101892"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Tsakogiannis, D., Nikolaidis, M., Zagouri, F., Zografos, E., Kottaridi, C., Kyriakopoulou, Z., Tzioga, L., Markoulatos, P., Amoutzias, G.D., and Bletsa, G. (2022). Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas. Viruses, 15.","DOI":"10.3390\/v15010141"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.274.9.5810","article-title":"The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-Surface Glycosaminoglycans on Human Keratinocytes","volume":"274","author":"Joyce","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the Minor Capsid Protein of Papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1128\/JVI.78.22.12179-12188.2004","article-title":"The L2 Minor Capsid Protein of Human Papillomavirus Type 16 Interacts with a Network of Nuclear Import Receptors","volume":"78","author":"Darshan","year":"2004","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/tra.12137","article-title":"Viral Subversion of Nucleocytoplasmic Trafficking","volume":"15","author":"Yarbrough","year":"2014","journal-title":"Traffic"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"23958","DOI":"10.1074\/jbc.M200724200","article-title":"Nuclear Import Strategies of High Risk HPV16 L1 Major Capsid Protein","volume":"277","author":"Nelson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Morante, A.V., Baboolal, D.D., Simon, X., Pan, E.C.-Y., and Meneses, P.I. (2022). Human Papillomavirus Minor Capsid Protein L2 Mediates Intracellular Trafficking into and Passage beyond the Endoplasmic Reticulum. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01505-22"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Li, X., Jiao, Y., and Wu, C. (2022). High-Risk Human Papillomavirus Oncogenic E6\/E7 MRNAs Splicing Regulation. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.929666"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2013.07.008","article-title":"The E4 Protein; Structure, Function and Patterns of Expression","volume":"445","author":"Doorbar","year":"2013","journal-title":"Virology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/JCM.37.7.2270-2273.1999","article-title":"Detection of Human Papillomavirus Types 6 and 11 in Pubic and Perianal Hair from Patients with Genital Warts","volume":"37","author":"Boxman","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Budhwani, M., Lukowski, S.W., Porceddu, S.V., Frazer, I.H., and Chandra, J. (2020). Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00307"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","article-title":"Cleavage of the Papillomavirus Minor Capsid Protein, L2, at a Furin Consensus Site Is Necessary for Infection","volume":"103","author":"Richards","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Surviladze, Z., Dziduszko, A., and Ozbun, M.A. (2012). Essential Roles for Soluble Virion-Associated Heparan Sulfonated Proteoglycans and Growth Factors in Human Papillomavirus Infections. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002519"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.04.007","article-title":"Usage of Heparan Sulfate, Integrins, and FAK in HPV16 Infection","volume":"403","author":"Abban","year":"2010","journal-title":"Virology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/jvi.71.3.2449-2456.1997","article-title":"Identification of the Alpha6 Integrin as a Candidate Receptor for Papillomaviruses","volume":"71","author":"Evander","year":"1997","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JVI.02906-12","article-title":"Tetraspanin CD151 Mediates Papillomavirus Type 16 Endocytosis","volume":"87","author":"Scheffer","year":"2013","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1128\/JVI.00724-06","article-title":"Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent Cells","volume":"80","author":"Culp","year":"2006","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1128\/JVI.77.24.13125-13135.2003","article-title":"Different Heparan Sulfate Proteoglycans Serve as Cellular Receptors for Human Papillomaviruses","volume":"77","author":"Handisurya","year":"2003","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Woodham, A.W., Da Silva, D.M., Skeate, J.G., Raff, A.B., Ambroso, M.R., Brand, H.E., Isas, J.M., Langen, R., and Kast, W.M. (2012). The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043519"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1128\/JVI.00519-13","article-title":"Annexin A2 and S100A10 Regulate Human Papillomavirus Type 16 Entry and Intracellular Trafficking in Human Keratinocytes","volume":"87","author":"Dziduszko","year":"2013","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/JVI.05606-11","article-title":"Identification and Analysis of Papillomavirus E2 Protein Binding Sites in the Human Genome","volume":"86","author":"Sudakov","year":"2012","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Pal, A., and Kundu, R. (2019). Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.03116"},{"key":"ref_81","first-page":"66","article-title":"Outcome Standards for Public Cancer Education: The Foundation for Community Education Programs","volume":"12","author":"Vega","year":"1985","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"White, E.A. (2019). Manipulation of Epithelial Differentiation by HPV Oncoproteins. Viruses, 11.","DOI":"10.3390\/v11040369"},{"key":"ref_83","first-page":"141","article-title":"Human Papillomavirus Type 18 and Intraepithelial Lesions of the Cervix","volume":"144","author":"McLachlin","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","article-title":"Human Papillomavirus Type 16 and 18 Gene Expression in Cervical Neoplasias","volume":"23","author":"Stoler","year":"1992","journal-title":"Hum. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1128\/JVI.77.19.10186-10201.2003","article-title":"Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers","volume":"77","author":"Middleton","year":"2003","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/1541-7786.MCR-20-0491","article-title":"Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation","volume":"19","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1128\/JVI.00153-13","article-title":"Human Papillomaviruses Modulate MicroRNA 145 Expression to Directly Control Genome Amplification","volume":"87","author":"Gunasekharan","year":"2013","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virusres.2016.11.016","article-title":"Control of Human Papillomavirus Gene Expression by Alternative Splicing","volume":"231","author":"Graham","year":"2017","journal-title":"Virus Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrmicro2984","article-title":"Regulation of Human Papillomavirus Gene Expression by Splicing and Polyadenylation","volume":"11","author":"Johansson","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Guion, L., Bienkowska-Haba, M., DiGiuseppe, S., Florin, L., and Sapp, M. (2019). PML Nuclear Body-Residing Proteins Sequentially Associate with HPV Genome after Infectious Nuclear Delivery. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007590"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13027-023-00488-w","article-title":"The complexity of human papilloma virus in cancers: A narrative review","volume":"18","author":"Sofiani","year":"2023","journal-title":"Infect. Agent Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Calton, C.M., Bronnimann, M.P., Manson, A.R., Li, S., Chapman, J.A., Suarez-Berumen, M., Williamson, T.R., Molugu, S.K., Bernal, R.A., and Campos, S.K. (2017). Translocation of the Papillomavirus L2\/VDNA Complex across the Limiting Membrane Requires the Onset of Mitosis. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006200"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3851\/IMP2612","article-title":"Targeting Human Papillomavirus Genome Replication for Antiviral Drug Discovery","volume":"18","author":"Archambault","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Edwards, T.G., Vidmar, T.J., Koeller, K., Bashkin, J.K., and Fisher, C. (2013). DNA Damage Repair Genes Controlling Human Papillomavirus (HPV) Episome Levels under Conditions of Stability and Extreme Instability. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075406"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human Papillomavirus and Cervical Cancer","volume":"40","author":"Okunade","year":"2020","journal-title":"J. Obs. Gynaecol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ijc.29082","article-title":"EUROGIN 2014 Roadmap: Differences in Human Papillomavirus Infection Natural History, Transmission and Human Papillomavirus-Related Cancer Incidence by Gender and Anatomic Site of Infection","volume":"136","author":"Giuliano","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","article-title":"HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Schrank, T.P., Kim, S., Rehmani, H., Kothari, A., Wu, D., Yarbrough, W.G., and Issaeva, N. (2022). Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration. Cancers, 14.","DOI":"10.3390\/cancers14184488"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1399-3011.1989.tb01009.x","article-title":"Crystallographic Characterization of Conformation of 1-Aminocyclopropane-1-Carboxylic Acid Residue (Ac3c) in Simple Derivatives and Peptides","volume":"34","author":"Valle","year":"1989","journal-title":"Int. J. Pept. Protein Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA Damage, Repair, and Mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Yeo-Teh, N.S.L., Ito, Y., and Jha, S. (2018). High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061706"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human Papillomavirus Molecular Biology and Disease Association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"21573","DOI":"10.1073\/pnas.1906120116","article-title":"Human Papillomavirus 16 Promotes Microhomology-Mediated End-Joining","volume":"116","author":"Leeman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Witzany, G. (2012). Viruses: Essential Agents of Life, Springer.","DOI":"10.1007\/978-94-007-4899-6"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.30588","article-title":"Human Papillomavirus in Cervical Cancer and Oropharyngeal Cancer: One Cause, Two Diseases","volume":"123","author":"Berman","year":"2017","journal-title":"Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4102\/ojvr.v82i1.858","article-title":"A Review on the Effect of Macrocyclic Lactones on Dung-Dwelling Insects: Toxicity of Macrocyclic Lactones to Dung Beetles","volume":"82","author":"Jacobs","year":"2015","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2020.00188","article-title":"The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease","volume":"11","author":"Garbuglia","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000506725","article-title":"HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer","volume":"64","author":"Leite","year":"2020","journal-title":"Acta Cytol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3257939","DOI":"10.1155\/2019\/3257939","article-title":"Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1016\/j.vaccine.2012.04.106","article-title":"Human Papillomavirus Vaccines--Immune Responses","volume":"30","author":"Stanley","year":"2012","journal-title":"Vaccine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 Major Capsid Protein Self-Assembles into Virus-like Particles That Are Highly Immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","article-title":"Efficacy and Safety of Prophylactic HPV Vaccines. A Cochrane Review of Randomized Trials","volume":"17","author":"Arbyn","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic Vaccines for High-Risk HPV-Associated Diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1517\/13543784.17.7.1051","article-title":"Clinical Investigations of Toll-like Receptor Agonists","volume":"17","author":"Meyer","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small Anti-Viral Compounds Activate Immune Cells via the TLR7 MyD88-Dependent Signaling Pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/14656566.5.2.427","article-title":"Imiquimod as a Dermatological Therapy","volume":"5","author":"Tran","year":"2004","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.0366-077X.2003.05628.x","article-title":"Imiquimod: Modes of Action","volume":"149","author":"Bilu","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/187152609787847758","article-title":"Drug Targets in Cytomegalovirus Infection","volume":"9","author":"Andrei","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Amine, A., Rivera, S., Opolon, P., Dekkal, M., Biard, D.S.F., Bouamar, H., Louache, F., McKay, M.J., Bourhis, J., and Deutsch, E. (2009). Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6\/E7, CXCR4 and Rho\/ROCK Signaling in HPV Tumor Cells. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005018"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3851\/IMP1421","article-title":"Potential Risk Factors Associated with the Use of Cidofovir to Treat Benign Human Papillomavirus-Related Disease","volume":"14","author":"Donne","year":"2009","journal-title":"Antivir. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-9071(200002)60:2<205::AID-JMV16>3.0.CO;2-8","article-title":"Cidofovir, a New Approach for the Treatment of Cervix Intraepithelial Neoplasia Grade III (CIN III)","volume":"60","author":"Snoeck","year":"2000","journal-title":"J. Med. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Da Silva, M.L.R., De Albuquerque, B.H.D.R., Allyrio, T.A.D.M.F., De Almeida, V.D., Cobucci, R.N.D.O., Bezerra, F.L., Andrade, V.S., Lanza, D.C.F., De Azevedo, J.C.V., and De Ara\u00fajo, J.M.G. (2021). The Role of HPV-Induced Epigenetic Changes in Cervical Carcinogenesis (Review). Biomed. Rep., 15.","DOI":"10.3892\/br.2021.1436"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnbeh.2016.00107","article-title":"Waddington, Dynamic Systems, and Epigenetics","volume":"10","author":"Tronick","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e03274-20","DOI":"10.1128\/mBio.03274-20","article-title":"Histone Modifications in Papillomavirus Virion Minichromosomes","volume":"12","author":"Porter","year":"2021","journal-title":"mBio"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/jvi.21.3.1205-1209.1977","article-title":"Chromatin-like Structures Obtained after Alkaline Disruption of Bovine and Human Papillomaviruses","volume":"21","author":"Favre","year":"1977","journal-title":"J. Virol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e486s","DOI":"10.6061\/clinics\/2018\/e486s","article-title":"Regulation of HPV Transcription","volume":"73","author":"Ribeiro","year":"2018","journal-title":"Clinics"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Murakami, I., Iwata, T., Morisada, T., Tanaka, K., and Aoki, D. (2021). Nucleosome Positioning on Episomal Human Papillomavirus DNA in Cultured Cells. Pathogens, 10.","DOI":"10.21203\/rs.3.rs-153646\/v1"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e22512","DOI":"10.7554\/eLife.22512","article-title":"Nucleosomes Influence Multiple Steps during Replication Initiation","volume":"6","author":"Azmi","year":"2017","journal-title":"Elife"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virusres.2016.10.017","article-title":"The Human Papillomavirus E7 Oncoprotein as a Regulator of Transcription","volume":"231","author":"Songock","year":"2017","journal-title":"Virus Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/JCM.01106-13","article-title":"Methylation of Human Papillomavirus Type 16 CpG Sites at E2-Binding Site 1 (E2BS1), E2BS2, and the Sp1-Binding Site in Cervical Cancer Samples as Determined by High-Resolution Melting Analysis-PCR","volume":"51","author":"Jacquin","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.12997\/jla.2020.9.3.419","article-title":"The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis","volume":"9","author":"Lee","year":"2020","journal-title":"J. Lipid Atheroscler."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Liu, S., Chang, W., Jin, Y., Feng, C., Wu, S., He, J., and Xu, T. (2019). The Function of Histone Acetylation in Cervical Cancer Development. Biosci. Rep., 39.","DOI":"10.1042\/BSR20190527"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0960-9822(06)00296-X","article-title":"Acetylation of General Transcription Factors by Histone Acetyltransferases","volume":"7","author":"Imhof","year":"1997","journal-title":"Curr. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","article-title":"The CBP Co-Activator Is a Histone Acetyltransferase","volume":"384","author":"Bannister","year":"1996","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1038\/sj.onc.1206896","article-title":"Interaction between the HPV E7 Oncoprotein and the Transcriptional Coactivator P300","volume":"22","author":"Bernat","year":"2003","journal-title":"Oncogene"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","article-title":"P300\/CBP Inhibition Enhances the Efficacy of Programmed Death-Ligand 1 Blockade Treatment in Prostate Cancer","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Langsfeld, E.S., Bodily, J.M., and Laimins, L.A. (2015). The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005181"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e00263-19","DOI":"10.1128\/mBio.00263-19","article-title":"Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation","volume":"10","author":"Das","year":"2019","journal-title":"mBio"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1038\/onc.2016.8","article-title":"HPV16 Oncogene Expression Levels during Early Cervical Carcinogenesis Are Determined by the Balance of Epigenetic Chromatin Modifications at the Integrated Virus Genome","volume":"35","author":"Groves","year":"2016","journal-title":"Oncogene"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Gautam, D., Johnson, B.A., Mac, M., and Moody, C.A. (2018). SETD2-Dependent H3K36me3 Plays a Critical Role in Epigenetic Regulation of the HPV31 Life Cycle. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007367"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1074\/jbc.272.13.8236","article-title":"DNA Binding and Bending by the Human Papillomavirus Type 16 E2 Protein. Recognition of an Extended Binding Site","volume":"272","author":"Thain","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1128\/JVI.77.23.12450-12459.2003","article-title":"Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection","volume":"77","author":"Kim","year":"2003","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","article-title":"Metabolic Reprogramming and Epigenetic Modifications in Cancer: From the Impacts and Mechanisms to the Treatment Potential","volume":"55","author":"Xu","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Kumar, S., Gonzalez, E.A., Rameshwar, P., and Etchegaray, J.-P. (2020). Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies. Cancers, 12.","DOI":"10.3390\/cancers12123657"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","article-title":"The Role of DNA Methylation in Cancer","volume":"945","author":"Lakshminarasimhan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Audia, J.E., and Campbell, R.M. (2016). Histone Modifications and Cancer. Cold Spring Harb. Perspect. Biol., 8.","DOI":"10.1101\/cshperspect.a019521"},{"key":"ref_147","first-page":"11","article-title":"Modulation of DNA Methylation by Human Papillomavirus E6 and E7 Oncoproteins in Cervical Cancer","volume":"15","author":"Sen","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-11-17","article-title":"Genetic Variants of P27 and P21 as Predictors for Risk of Second Primary Malignancy in Patients with Index Squamous Cell Carcinoma of Head and Neck","volume":"11","author":"Wang","year":"2012","journal-title":"Mol. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3892\/br.2014.298","article-title":"Promoter Region Methylation and Loss of Protein Expression of PTEN and Significance in Cervical Cancer","volume":"2","author":"Qi","year":"2014","journal-title":"Biomed. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/pro.3159","article-title":"Nucleosome Mobility and the Regulation of Gene Expression: Insights from Single-Molecule Studies","volume":"26","author":"Rudnizky","year":"2017","journal-title":"Protein Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13148-017-0424-5","article-title":"Novel Insights into Epigenetic Drivers of Oropharyngeal Squamous Cell Carcinoma: Role of HPV and Lifestyle Factors","volume":"9","author":"Furlan","year":"2017","journal-title":"Clin. Epigenet."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1369\/0022155413506582","article-title":"Histone Deacetylases: A Saga of Perturbed Acetylation Homeostasis in Cancer","volume":"62","author":"Parbin","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"96323","DOI":"10.18632\/oncotarget.22036","article-title":"Direct HPV E6\/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40291-018-0336-x","article-title":"Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis","volume":"22","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"46163","DOI":"10.18632\/oncotarget.17575","article-title":"5azadC Treatment Upregulates MiR-375 Level and Represses HPV16 E6 Expression","volume":"8","author":"Morel","year":"2017","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Giannopoulou, A.F., Velentzas, A.D., Konstantakou, E.G., Avgeris, M., Katarachia, S.A., Papandreou, N.C., Kalavros, N.I., Mpakou, V.E., Iconomidou, V., and Anastasiadou, E. (2019). Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061291"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-virology-100114-055021","article-title":"Novel Functions of the Human Papillomavirus E6 Oncoproteins","volume":"2","author":"Wallace","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-17-2118","article-title":"E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C","volume":"78","author":"Chen","year":"2018","journal-title":"Cancer Res."},{"key":"ref_159","first-page":"320","article-title":"Molecular Pathways in the Development of HPV-Induced Cervical Cancer","volume":"20","author":"Baghbanzadeh","year":"2021","journal-title":"EXCLI J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"581007","DOI":"10.3389\/fonc.2020.581007","article-title":"MicroRNAs Biogenesis, Functions and Role in Tumor Angiogenesis","volume":"10","author":"Annese","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1007\/s13277-015-3465-4","article-title":"Long Noncoding RNA CCHE1 Promotes Cervical Cancer Cell Proliferation via Upregulating PCNA","volume":"36","author":"Yang","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"12796","DOI":"10.1002\/jcb.28550","article-title":"CCEPR Is a Novel Clinical Biomarker for Prognosis and Regulates Cell Proliferation through PCNA in Osteosarcoma","volume":"120","author":"Teng","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biopha.2016.06.056","article-title":"Long Noncoding RNA CCHE1 Indicates a Poor Prognosis of Hepatocellular Carcinoma and Promotes Carcinogenesis via Activation of the ERK\/MAPK Pathway","volume":"83","author":"Peng","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1038\/srep11724","article-title":"Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis","volume":"5","author":"Sharma","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Carse, S., Bergant, M., and Sch\u00e4fer, G. (2021). Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042201"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Rajan, P.K., Udoh, U.-A., Sanabria, J.D., Banerjee, M., Smith, G., Schade, M.S., Sanabria, J., Sodhi, K., Pierre, S., and Xie, Z. (2020). The Role of Histone Acetylation-\/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238894"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18632\/genesandcancer.65","article-title":"Histone Acetyltransferases and Histone Deacetylases in B- and T-Cell Development, Physiology and Malignancy","volume":"6","author":"Haery","year":"2015","journal-title":"Genes Cancer"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e52774","DOI":"10.15252\/embr.202152774","article-title":"Histone Acylations and Chromatin Dynamics: Concepts, Challenges, and Links to Metabolism","volume":"22","author":"Nitsch","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Eckschlager, T., Plch, J., Stiborova, M., and Hrabeta, J. (2017). Histone Deacetylase Inhibitors as Anticancer Drugs. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071414"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"211","DOI":"10.32604\/or.2022.026913","article-title":"Histone Deacetylase Inhibitors as a Novel Therapeutic Approach for Pheochromocytomas and Paragangliomas","volume":"30","author":"Manta","year":"2022","journal-title":"Oncol. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejmech.2018.08.073","article-title":"HDAC as Onco Target: Reviewing the Synthetic Approaches with SAR Study of Their Inhibitors","volume":"158","author":"Sangwan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2018.12.039","article-title":"Histone Deacetylase 8 (HDAC8) and Its Inhibitors with Selectivity to Other Isoforms: An Overview","volume":"164","author":"Banerjee","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting Histone Deacetylases for Cancer Therapy: Trends and Challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddab370","article-title":"The Anti-Inflammatory Mechanism of SAHA in Acute Pancreatitis through HDAC5\/SLIT2\/Akt\/\u03b2-Catenin Axis","volume":"31","author":"Tong","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.3.6.7273","article-title":"The Role of Histone Deacetylases in Prostate Cancer","volume":"3","author":"Abbas","year":"2008","journal-title":"Epigenetics"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1078-0432.CCR-08-1813","article-title":"Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment","volume":"15","author":"Lin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"E11138","DOI":"10.1073\/pnas.1801156115","article-title":"Vorinostat, a Pan-HDAC Inhibitor, Abrogates Productive HPV-18 DNA Amplification","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/cbdd.12787","article-title":"PXD101 Analogs with L-Phenylglycine-Containing Branched Cap as Histone Deacetylase Inhibitors","volume":"88","author":"Li","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2146\/ajhp150487","article-title":"Panobinostat: A Histone Deacetylase Inhibitor for the Treatment of Relapsed or Refractory Multiple Myeloma","volume":"73","author":"Wahaib","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.biopha.2016.10.057","article-title":"Panobinostat Induces Apoptosis via Production of Reactive Oxygen Species and Synergizes with Topoisomerase Inhibitors in Cervical Cancer Cells","volume":"84","author":"Wasim","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_183","first-page":"601","article-title":"Transcriptional Regulation of E-Cadherin and Oncoprotein E7 by Valproic Acid in HPV Positive Cell Lines","volume":"19","author":"Faghihloo","year":"2016","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1007\/s12032-010-9700-3","article-title":"A Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Chemotherapy plus Epigenetic Therapy with Hydralazine Valproate for Advanced Cervical Cancer. Preliminary Results","volume":"28","author":"Coronel","year":"2011","journal-title":"Med. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jop.13039","article-title":"Entinostat Is a Novel Therapeutic Agent to Treat Oral Squamous Cell Carcinoma","volume":"49","author":"Marques","year":"2020","journal-title":"J. Oral. Pathol. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2650309","article-title":"DNA Methylation. The Effect of Minor Bases on DNA-Protein Interactions","volume":"265","author":"Adams","year":"1990","journal-title":"Biochem. J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The Epigenomics of Cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Cui, D., and Xu, X. (2018). DNA Methyltransferases, DNA Methylation, and Age-Associated Cognitive Function. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051315"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0092-8674(92)90561-P","article-title":"A Targeting Sequence Directs DNA Methyltransferase to Sites of DNA Replication in Mammalian Nuclei","volume":"71","author":"Leonhardt","year":"1992","journal-title":"Cell"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/nar\/26.4.1038","article-title":"Multiple Domains Are Involved in the Targeting of the Mouse DNA Methyltransferase to the DNA Replication Foci","volume":"26","author":"Liu","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/jmbi.1997.1125","article-title":"DNA (Cytosine-5)-Methyltransferases in Mouse Cells and Tissues. Studies with a Mechanism-Based Probe","volume":"270","author":"Yoder","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"27816","DOI":"10.1074\/jbc.M400181200","article-title":"DNMT3L Stimulates the DNA Methylation Activity of Dnmt3a and Dnmt3b through a Direct Interaction","volume":"279","author":"Suetake","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA Methylation and Cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv. Genet."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/15592294.2019.1638701","article-title":"DNA Hypermethylation in Disease: Mechanisms and Clinical Relevance","volume":"14","author":"Ehrlich","year":"2019","journal-title":"Epigenetics"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Chen, C., Wang, Z., Ding, Y., Wang, L., Wang, S., Wang, H., and Qin, Y. (2022). DNA Methylation: From Cancer Biology to Clinical Perspectives. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2712326"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/1078-0432.CCR-17-1438","article-title":"Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer","volume":"23","author":"Biktasova","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"886613","DOI":"10.3389\/fgene.2022.886613","article-title":"Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications","volume":"13","year":"2022","journal-title":"Front. Genet."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1007\/s11033-021-06752-9","article-title":"Harnessing the Immune System against Cancer: Current Immunotherapy Approaches and Therapeutic Targets","volume":"48","author":"Kumar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Maffuid, K., and Cao, Y. (2023). Decoding the Complexity of Immune-Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy. Cancers, 15.","DOI":"10.3390\/cancers15164188"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Alnefaie, A., Albogami, S., Asiri, Y., Ahmad, T., Alotaibi, S.S., Al-Sanea, M.M., and Althobaiti, H. (2022). Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.797440"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Moreno, C., Haynie, C., Cheever, A., and Weber, K.S. (2022). Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071493"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Zhang, C., Liu, J., Zhong, J.F., and Zhang, X. (2017). Engineering CAR-T Cells. Biomark. Res., 5.","DOI":"10.1186\/s40364-017-0102-y"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"De Marco, R.C., Monzo, H.J., and Ojala, P.M. (2023). CAR T Cell Therapy: A Versatile Living Drug. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076300"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e003354","DOI":"10.1136\/jitc-2021-003354","article-title":"4-1BB and Optimized CD28 Co-Stimulation Enhances Function of Human Mono-Specific and Bi-Specific Third-Generation CAR T Cells","volume":"9","author":"Roselli","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41423-021-00732-6","article-title":"Chimeric Antigen Receptor- and Natural Killer Cell Receptor-Engineered Innate Killer Cells in Cancer Immunotherapy","volume":"18","author":"Zhang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/2159-8290.CD-20-1661","article-title":"IFN\u03b3 Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity","volume":"11","author":"Alizadeh","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1019115","DOI":"10.3389\/fimmu.2022.1019115","article-title":"CAR-T Cell Therapy for Hematological Malignancies: Limitations and Optimization Strategies","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T Therapies in Solid Tumors: Opportunities and Challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1105265","DOI":"10.3389\/fimmu.2023.1105265","article-title":"T Cell Immunotherapy for Cervical Cancer: Challenges and Opportunities","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3892\/ol.2022.13478","article-title":"Current Progress in CAR-T Cell Therapy for Tumor Treatment","volume":"24","author":"Chen","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T Cell Receptor-Based Cancer Immunotherapy: Emerging Efficacy and Pathways of Resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Menon, A.P., Moreno, B., Meraviglia-Crivelli, D., Nonatelli, F., Villanueva, H., Barainka, M., Zheleva, A., van Santen, H.M., and Pastor, F. (2023). Modulating T Cell Responses by Targeting CD3. Cancers, 15.","DOI":"10.3390\/cancers15041189"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A Guide to Cancer Immunotherapy: From T Cell Basic Science to Clinical Practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"850358","DOI":"10.3389\/fimmu.2022.850358","article-title":"Emerging Strategies in TCR-Engineered T Cells","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Rs, J. (2021). The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.649815"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.drudis.2019.07.011","article-title":"Cervical Cancer and HPV Infection: Ongoing Therapeutic Research to Counteract the Action of E6 and E7 Oncoproteins","volume":"24","author":"Almeida","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"e99488","DOI":"10.1172\/jci.insight.99488","article-title":"Engineered T Cells Targeting E7 Mediate Regression of Human Papillomavirus Cancers in a Murine Model","volume":"3","author":"Jin","year":"2018","journal-title":"JCI Insight"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"216242","DOI":"10.1016\/j.canlet.2023.216242","article-title":"A Costimulatory Chimeric Antigen Receptor Targeting TROP2 Enhances the Cytotoxicity of NK Cells Expressing a T Cell Receptor Reactive to Human Papillomavirus Type 16 E7","volume":"566","author":"Poorebrahim","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Zhu, Y. (2022). Advances in CRISPR\/Cas9. Biomed. Res. Int., 2022.","DOI":"10.1155\/2022\/9978571"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Najafi, S., Tan, S.C., Aghamiri, S., Raee, P., Ebrahimi, Z., Jahromi, Z.K., Rahmati, Y., Sadri Nahand, J., Piroozmand, A., and Jajarmi, V. (2022). Therapeutic Potentials of CRISPR-Cas Genome Editing Technology in Human Viral Infections. Biomed. Pharmacother., 148.","DOI":"10.1016\/j.biopha.2022.112743"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In Vitro and in Vivo Growth Suppression of Human Papillomavirus 16-Positive Cervical Cancer Cells by CRISPR\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/s41598-017-17180-w","article-title":"CRISPR\/Cas9 Delivery with One Single Adenoviral Vector Devoid of All Viral Genes","volume":"7","author":"Schiwon","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ymthe.2019.08.012","article-title":"Systemic Delivery of CRISPR\/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors","volume":"27","author":"Jubair","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Ehrke-Schulz, E., Heinemann, S., Schulte, L., Schiwon, M., and Ehrhardt, A. (2020). Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR\/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells. Cancers, 12.","DOI":"10.3390\/cancers12071934"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1002\/hed.24072","article-title":"Human Papillomavirus Status and Gene Expression Profiles of Oropharyngeal and Oral Cancers from European American and African American Patients","volume":"38","author":"Tomar","year":"2016","journal-title":"Head Neck"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2020.12.005","article-title":"HPV-Inactive Cell Populations Arise from HPV16-Transformed Human Keratinocytes after P53 Knockout","volume":"554","author":"Abboodi","year":"2021","journal-title":"Virology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/23\/5583\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:30:07Z","timestamp":1760131807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/23\/5583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":226,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["cancers15235583"],"URL":"https:\/\/doi.org\/10.3390\/cancers15235583","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,25]]}}}